A genomic case study of desmoplastic small round cell tumor: comprehensive analysis reveals insights into potential therapeutic targets and development of a monitoring tool for a rare and aggressive disease.

Continuous efforts to establish the genomic landscape of rare diseases, frequently neglected in large sequencing consortiums, are highly significant to improve the knowledge of defective pathways involved with tumor onset in general, in addition to the strong potential of revealing druggable targets for clinical use.

also in 132,142 other papers